Decheng Capital LLC Pyxis Oncology, Inc. Transaction History
Decheng Capital LLC
- $396 Billion
- Q2 2025
A detailed history of Decheng Capital LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 326,810 shares of PYXS stock, worth $859,510. This represents 0.09% of its overall portfolio holdings.
Number of Shares
326,810
Previous 326,810
-0.0%
Holding current value
$859,510
Previous $320 Million
12.26%
% of portfolio
0.09%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$9.54 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$9.31 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$7.33 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$6.58 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$5.65 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $92.3M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...